A two-gene epigenetic signature for the prediction of response to neoadjuvant chemotherapy in triple-negative breast cancer patients

被引：0
|
作者：
Begoña Pineda
Angel Diaz-Lagares
José Alejandro Pérez-Fidalgo
Octavio Burgués
Inés González-Barrallo
Ana B. Crujeiras
Juan Sandoval
Manel Esteller
Ana Lluch
Pilar Eroles
机构：
[1] Biomedical Research Institute (INCLIVA),Department of Physiology, Faculty of Medicine
[2] University of Valencia,Present Address: Cancer Epigenomics, Translational Medical Oncology (Oncomet)
[3] Centro de Investigacion Biomedica en Red Cancer (CIBERONC),Oncology Department
[4] Cancer Epigenetics and Biology Program (PEBC),Pathology Department
[5] Bellvitge Biomedical Research Institute (IDIBELL),Present Address: Laboratory of Epigenomics in Endocrinology and Nutrition
[6] Health Research Institute of Santiago (IDIS),Biomarkers and Precision Medicne Unit (UByMP)
[7] University Clinical Hospital of Santiago (CHUS/SERGAS),Physiological Sciences Department, School of Medicine and Health Sciences
[8] CIBERONC,undefined
[9] Hospital Clínico Universitario de Valencia,undefined
[10] Hospital Clínico Universitario de Valencia,undefined
[11] Instituto de Investigacion Sanitaria (IDIS),undefined
[12] Complejo Hospitalario Universitario de Santiago (CHUS),undefined
[13] Santiago de Compostela University (USC) and CIBER Fisiopatologia de la Obesidad y Nutricion (CIBERobn),undefined
[14] Instituto de Investigación Sanitaria La Fe (IISLaFeValencia),undefined
[15] University of Barcelona (UB),undefined
[16] Institució Catalana de Recerca i Estudis Avançats (ICREA),undefined
[17] Institució Catalana de Recerca i Estudis Avançats (ICREA),undefined
[18] COST action,undefined
来源：
Clinical Epigenetics | 2019年 / 11卷
关键词：
Triple-negative breast cancer; Prediction; Epigenetic signature;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Prediction of pathological complete response and prognosis in patients with neoadjuvant treatment for triple-negative breast cancer
    Paul Gass
    Michael P. Lux
    Claudia Rauh
    Alexander Hein
    Mayada R. Bani
    Cornelia Fiessler
    Arndt Hartmann
    Lothar Häberle
    Jutta Pretscher
    Ramona Erber
    David L. Wachter
    Rüdiger Schulz-Wendtland
    Matthias W. Beckmann
    Peter A. Fasching
    Marius Wunderle
    [J]. BMC Cancer, 18
  • [22] Prediction of pathological complete response and prognosis in patients with neoadjuvant treatment for triple-negative breast cancer
    Gass, Paul
    Lux, Michael P.
    Rauh, Claudia
    Hein, Alexander
    Bani, Mayada R.
    Fiessler, Cornelia
    Hartmann, Arndt
    Haeberle, Lothar
    Pretscher, Jutta
    Erber, Ramona
    Wachter, David L.
    Schulz-Wendtland, Ruediger
    Beckmann, Matthias W.
    Fasching, Peter A.
    Wunderle, Marius
    [J]. BMC CANCER, 2018, 18
  • [23] An immunological signature to predict outcome in patients with triple-negative breast cancer with residual disease after neoadjuvant chemotherapy
    Blaye, C.
    Darbo, E.
    Debled, M.
    Brouste, V
    Velasco, V.
    Pinard, C.
    Larmonier, N.
    Pellegrin, I
    Tarricone, A.
    Arnedos, M.
    Commeny, J.
    Bonnefoi, H.
    Larmonier, C.
    MacGrogan, G.
    [J]. ESMO OPEN, 2022, 7 (04)
  • [24] An immunological signature to predict outcome in patients with triple-negative breast cancer with residual disease after neoadjuvant chemotherapy
    Blaye, C.
    Darbo, E.
    Debled, M.
    Brouste, V.
    Velasco, V.
    Pinard, C.
    Pellegrin, I.
    Tarricone, A.
    Arnedos, M.
    Commeny, J.
    Bonnefoi, H.
    Larmonier, C.
    Macgrogan, G.
    [J]. ANNALS OF ONCOLOGY, 2022, 33 : S127 - S127
  • [25] Tumor Microenvironment Can Predict Chemotherapy Response of Patients with Triple-Negative Breast Cancer Receiving Neoadjuvant Chemotherapy
    Kim, Dongjin
    Yu, Yeuni
    Jung, Ki Sun
    Kim, Yun Hak
    Kim, Jae-Joon
    [J]. CANCER RESEARCH AND TREATMENT, 2024, 56 (01): : 162 - 177
  • [26] Prediction of Tumor Progression During Neoadjuvant Chemotherapy and Survival Outcome in Patients With Triple-Negative Breast Cancer
    Yoen, Heera
    Kim, Soo-Yeon
    Lee, Dae-Won
    Lee, Han-Byoel
    Cho, Nariya
    [J]. KOREAN JOURNAL OF RADIOLOGY, 2023, 24 (07) : 626 - 639
  • [27] BRCAness and prognosis in triple-negative breast cancer patients treated with neoadjuvant chemotherapy
    Tanino, Hirokazu
    Kosaka, Yoshimasa
    Sengoku, Norihiko
    Waraya, Mina
    Nishimiya, Hiroshi
    Katoh, Hirozhi
    Kikuchi, Mariko
    Minatani, Naoko
    Teraoka, Saeko
    Enomoto, Takumo
    Sato, Takeo
    Masahiko, Masahiko
    [J]. CANCER RESEARCH, 2015, 75
  • [28] BRCAness and Prognosis in Triple-Negative Breast Cancer Patients Treated with Neoadjuvant Chemotherapy
    Tanino, Hirokazu
    Kosaka, Yoshimasa
    Nishimiya, Hiroshi
    Tanaka, Youko
    Minatani, Naoko
    Kikuchi, Mariko
    Shida, Akiko
    Waraya, Mina
    Katoh, Hiroshi
    Enomoto, Takumo
    Sengoku, Norihiko
    Kajita, Sabine
    Hoffman, Robert M.
    Watanabe, Masahiko
    [J]. PLOS ONE, 2016, 11 (12):
  • [29] Validation of an immunomodulatory gene signature algorithm to predict response to neoadjuvant immunochemotherapy in patients with primary triple-negative breast cancer.
    Iwase, Toshiaki
    Pusztai, Lajos
    Blenman, Kim
    Li, Xiaotong
    Seitz, Robert
    Nielsen, Tyler J.
    Schweitzer, Brock L.
    Hout, David Richard
    Bailey, Dan B.
    Zhang, Xiang
    Shen, Yichao
    Ueno, Naoto T.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [30] Neoadjuvant and Adjuvant Chemotherapy Considerations for Triple-Negative Breast Cancer
    Stover, Daniel G.
    Bell, Caitlin F.
    Tolaney, Sara M.
    [J]. AMERICAN JOURNAL OF HEMATOLOGY-ONCOLOGY, 2016, 12 (03) : 6 - 12
12345